nodes	percent_of_prediction	percent_of_DWPC	metapath
Anidulafungin—Mediastinal disorder—Vandetanib—thyroid cancer	0.00474	0.00474	CcSEcCtD
Anidulafungin—Abdominal pain upper—Sorafenib—thyroid cancer	0.00469	0.00469	CcSEcCtD
Anidulafungin—Hypokalaemia—Sorafenib—thyroid cancer	0.00467	0.00467	CcSEcCtD
Anidulafungin—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.00462	0.00462	CcSEcCtD
Anidulafungin—Mental disorder—Vandetanib—thyroid cancer	0.00461	0.00461	CcSEcCtD
Anidulafungin—Hypernatraemia—Doxorubicin—thyroid cancer	0.0046	0.0046	CcSEcCtD
Anidulafungin—Malnutrition—Vandetanib—thyroid cancer	0.00458	0.00458	CcSEcCtD
Anidulafungin—Alanine aminotransferase increased—Sorafenib—thyroid cancer	0.00453	0.00453	CcSEcCtD
Anidulafungin—Vision blurred—Vandetanib—thyroid cancer	0.00432	0.00432	CcSEcCtD
Anidulafungin—Thrombocytosis—Epirubicin—thyroid cancer	0.0042	0.0042	CcSEcCtD
Anidulafungin—Neutropenia—Sorafenib—thyroid cancer	0.00415	0.00415	CcSEcCtD
Anidulafungin—Oral candidiasis—Epirubicin—thyroid cancer	0.00411	0.00411	CcSEcCtD
Anidulafungin—Hypomagnesaemia—Epirubicin—thyroid cancer	0.00411	0.00411	CcSEcCtD
Anidulafungin—Cough—Vandetanib—thyroid cancer	0.004	0.004	CcSEcCtD
Anidulafungin—Pneumonia—Sorafenib—thyroid cancer	0.00398	0.00398	CcSEcCtD
Anidulafungin—Convulsion—Vandetanib—thyroid cancer	0.00397	0.00397	CcSEcCtD
Anidulafungin—Hypertension—Vandetanib—thyroid cancer	0.00396	0.00396	CcSEcCtD
Anidulafungin—Infestation NOS—Sorafenib—thyroid cancer	0.00396	0.00396	CcSEcCtD
Anidulafungin—Infestation—Sorafenib—thyroid cancer	0.00396	0.00396	CcSEcCtD
Anidulafungin—Chest pain—Vandetanib—thyroid cancer	0.0039	0.0039	CcSEcCtD
Anidulafungin—Thrombocytosis—Doxorubicin—thyroid cancer	0.00389	0.00389	CcSEcCtD
Anidulafungin—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00387	0.00387	CcSEcCtD
Anidulafungin—Hypomagnesaemia—Doxorubicin—thyroid cancer	0.00381	0.00381	CcSEcCtD
Anidulafungin—Oral candidiasis—Doxorubicin—thyroid cancer	0.00381	0.00381	CcSEcCtD
Anidulafungin—Hypercalcaemia—Epirubicin—thyroid cancer	0.00376	0.00376	CcSEcCtD
Anidulafungin—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00374	0.00374	CcSEcCtD
Anidulafungin—Infection—Vandetanib—thyroid cancer	0.00372	0.00372	CcSEcCtD
Anidulafungin—Nervous system disorder—Vandetanib—thyroid cancer	0.00367	0.00367	CcSEcCtD
Anidulafungin—Thrombocytopenia—Vandetanib—thyroid cancer	0.00366	0.00366	CcSEcCtD
Anidulafungin—Skin disorder—Vandetanib—thyroid cancer	0.00363	0.00363	CcSEcCtD
Anidulafungin—Urinary tract disorder—Sorafenib—thyroid cancer	0.00351	0.00351	CcSEcCtD
Anidulafungin—Connective tissue disorder—Sorafenib—thyroid cancer	0.00349	0.00349	CcSEcCtD
Anidulafungin—Urethral disorder—Sorafenib—thyroid cancer	0.00348	0.00348	CcSEcCtD
Anidulafungin—Hypercalcaemia—Doxorubicin—thyroid cancer	0.00348	0.00348	CcSEcCtD
Anidulafungin—Pleural effusion—Epirubicin—thyroid cancer	0.00341	0.00341	CcSEcCtD
Anidulafungin—Insomnia—Vandetanib—thyroid cancer	0.00338	0.00338	CcSEcCtD
Anidulafungin—Dyspnoea—Vandetanib—thyroid cancer	0.00333	0.00333	CcSEcCtD
Anidulafungin—Flushing—Sorafenib—thyroid cancer	0.0033	0.0033	CcSEcCtD
Anidulafungin—Cardiac disorder—Sorafenib—thyroid cancer	0.0033	0.0033	CcSEcCtD
Anidulafungin—Dyspepsia—Vandetanib—thyroid cancer	0.00329	0.00329	CcSEcCtD
Anidulafungin—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00323	0.00323	CcSEcCtD
Anidulafungin—Angiopathy—Sorafenib—thyroid cancer	0.00322	0.00322	CcSEcCtD
Anidulafungin—Immune system disorder—Sorafenib—thyroid cancer	0.00321	0.00321	CcSEcCtD
Anidulafungin—Rigors—Epirubicin—thyroid cancer	0.0032	0.0032	CcSEcCtD
Anidulafungin—Mediastinal disorder—Sorafenib—thyroid cancer	0.0032	0.0032	CcSEcCtD
Anidulafungin—Constipation—Vandetanib—thyroid cancer	0.0032	0.0032	CcSEcCtD
Anidulafungin—Pleural effusion—Doxorubicin—thyroid cancer	0.00316	0.00316	CcSEcCtD
Anidulafungin—Mental disorder—Sorafenib—thyroid cancer	0.00311	0.00311	CcSEcCtD
Anidulafungin—Erythema—Sorafenib—thyroid cancer	0.00309	0.00309	CcSEcCtD
Anidulafungin—Malnutrition—Sorafenib—thyroid cancer	0.00309	0.00309	CcSEcCtD
Anidulafungin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00306	0.00306	CcSEcCtD
Anidulafungin—Rigors—Doxorubicin—thyroid cancer	0.00296	0.00296	CcSEcCtD
Anidulafungin—Abdominal pain—Vandetanib—thyroid cancer	0.00296	0.00296	CcSEcCtD
Anidulafungin—Body temperature increased—Vandetanib—thyroid cancer	0.00296	0.00296	CcSEcCtD
Anidulafungin—Ventricular extrasystoles—Epirubicin—thyroid cancer	0.00289	0.00289	CcSEcCtD
Anidulafungin—Anaemia—Sorafenib—thyroid cancer	0.00286	0.00286	CcSEcCtD
Anidulafungin—Angioedema—Sorafenib—thyroid cancer	0.00282	0.00282	CcSEcCtD
Anidulafungin—Leukopenia—Sorafenib—thyroid cancer	0.00277	0.00277	CcSEcCtD
Anidulafungin—Blood bilirubin increased—Epirubicin—thyroid cancer	0.00276	0.00276	CcSEcCtD
Anidulafungin—Cough—Sorafenib—thyroid cancer	0.0027	0.0027	CcSEcCtD
Anidulafungin—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.00268	0.00268	CcSEcCtD
Anidulafungin—Hypertension—Sorafenib—thyroid cancer	0.00267	0.00267	CcSEcCtD
Anidulafungin—Pruritus—Vandetanib—thyroid cancer	0.00265	0.00265	CcSEcCtD
Anidulafungin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00261	0.00261	CcSEcCtD
Anidulafungin—Injection site reaction—Epirubicin—thyroid cancer	0.0026	0.0026	CcSEcCtD
Anidulafungin—Hyperkalaemia—Epirubicin—thyroid cancer	0.00257	0.00257	CcSEcCtD
Anidulafungin—Diarrhoea—Vandetanib—thyroid cancer	0.00256	0.00256	CcSEcCtD
Anidulafungin—Blood bilirubin increased—Doxorubicin—thyroid cancer	0.00256	0.00256	CcSEcCtD
Anidulafungin—Anaphylactic shock—Sorafenib—thyroid cancer	0.00252	0.00252	CcSEcCtD
Anidulafungin—Infection—Sorafenib—thyroid cancer	0.00251	0.00251	CcSEcCtD
Anidulafungin—Candida infection—Epirubicin—thyroid cancer	0.0025	0.0025	CcSEcCtD
Anidulafungin—Nervous system disorder—Sorafenib—thyroid cancer	0.00247	0.00247	CcSEcCtD
Anidulafungin—Dizziness—Vandetanib—thyroid cancer	0.00247	0.00247	CcSEcCtD
Anidulafungin—Thrombocytopenia—Sorafenib—thyroid cancer	0.00247	0.00247	CcSEcCtD
Anidulafungin—Blood urea increased—Epirubicin—thyroid cancer	0.00247	0.00247	CcSEcCtD
Anidulafungin—Skin disorder—Sorafenib—thyroid cancer	0.00245	0.00245	CcSEcCtD
Anidulafungin—Injection site reaction—Doxorubicin—thyroid cancer	0.0024	0.0024	CcSEcCtD
Anidulafungin—Vomiting—Vandetanib—thyroid cancer	0.00238	0.00238	CcSEcCtD
Anidulafungin—Hyperkalaemia—Doxorubicin—thyroid cancer	0.00238	0.00238	CcSEcCtD
Anidulafungin—Rash maculo-papular—Epirubicin—thyroid cancer	0.00238	0.00238	CcSEcCtD
Anidulafungin—Rash—Vandetanib—thyroid cancer	0.00236	0.00236	CcSEcCtD
Anidulafungin—Dermatitis—Vandetanib—thyroid cancer	0.00236	0.00236	CcSEcCtD
Anidulafungin—Headache—Vandetanib—thyroid cancer	0.00234	0.00234	CcSEcCtD
Anidulafungin—Candida infection—Doxorubicin—thyroid cancer	0.00231	0.00231	CcSEcCtD
Anidulafungin—Blood urea increased—Doxorubicin—thyroid cancer	0.00228	0.00228	CcSEcCtD
Anidulafungin—Sepsis—Epirubicin—thyroid cancer	0.00227	0.00227	CcSEcCtD
Anidulafungin—Dyspnoea—Sorafenib—thyroid cancer	0.00225	0.00225	CcSEcCtD
Anidulafungin—Nausea—Vandetanib—thyroid cancer	0.00222	0.00222	CcSEcCtD
Anidulafungin—Dyspepsia—Sorafenib—thyroid cancer	0.00222	0.00222	CcSEcCtD
Anidulafungin—Phlebitis—Epirubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Anidulafungin—Rash maculo-papular—Doxorubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Anidulafungin—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.00218	0.00218	CcSEcCtD
Anidulafungin—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00218	0.00218	CcSEcCtD
Anidulafungin—Constipation—Sorafenib—thyroid cancer	0.00216	0.00216	CcSEcCtD
Anidulafungin—Eye pain—Epirubicin—thyroid cancer	0.0021	0.0021	CcSEcCtD
Anidulafungin—Sepsis—Doxorubicin—thyroid cancer	0.0021	0.0021	CcSEcCtD
Anidulafungin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00206	0.00206	CcSEcCtD
Anidulafungin—Phlebitis—Doxorubicin—thyroid cancer	0.00204	0.00204	CcSEcCtD
Anidulafungin—Hot flush—Epirubicin—thyroid cancer	0.00203	0.00203	CcSEcCtD
Anidulafungin—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.00202	0.00202	CcSEcCtD
Anidulafungin—Menopausal symptoms—Epirubicin—thyroid cancer	0.00201	0.00201	CcSEcCtD
Anidulafungin—Urticaria—Sorafenib—thyroid cancer	0.002	0.002	CcSEcCtD
Anidulafungin—Abdominal pain—Sorafenib—thyroid cancer	0.00199	0.00199	CcSEcCtD
Anidulafungin—Body temperature increased—Sorafenib—thyroid cancer	0.00199	0.00199	CcSEcCtD
Anidulafungin—Eye pain—Doxorubicin—thyroid cancer	0.00194	0.00194	CcSEcCtD
Anidulafungin—Hypoglycaemia—Epirubicin—thyroid cancer	0.00194	0.00194	CcSEcCtD
Anidulafungin—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00194	0.00194	CcSEcCtD
Anidulafungin—Hot flush—Doxorubicin—thyroid cancer	0.00188	0.00188	CcSEcCtD
Anidulafungin—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00186	0.00186	CcSEcCtD
Anidulafungin—Hypersensitivity—Sorafenib—thyroid cancer	0.00186	0.00186	CcSEcCtD
Anidulafungin—Hypoglycaemia—Doxorubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Anidulafungin—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00179	0.00179	CcSEcCtD
Anidulafungin—Pruritus—Sorafenib—thyroid cancer	0.00179	0.00179	CcSEcCtD
Anidulafungin—Blood creatinine increased—Epirubicin—thyroid cancer	0.00178	0.00178	CcSEcCtD
Anidulafungin—Dehydration—Epirubicin—thyroid cancer	0.00176	0.00176	CcSEcCtD
Anidulafungin—Liver function test abnormal—Epirubicin—thyroid cancer	0.00175	0.00175	CcSEcCtD
Anidulafungin—Abdominal pain upper—Epirubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Anidulafungin—Hypokalaemia—Epirubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Anidulafungin—Diarrhoea—Sorafenib—thyroid cancer	0.00173	0.00173	CcSEcCtD
Anidulafungin—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Anidulafungin—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Anidulafungin—Dizziness—Sorafenib—thyroid cancer	0.00167	0.00167	CcSEcCtD
Anidulafungin—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00164	0.00164	CcSEcCtD
Anidulafungin—Dehydration—Doxorubicin—thyroid cancer	0.00163	0.00163	CcSEcCtD
Anidulafungin—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Anidulafungin—Vomiting—Sorafenib—thyroid cancer	0.0016	0.0016	CcSEcCtD
Anidulafungin—Abdominal pain upper—Doxorubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Anidulafungin—Hypokalaemia—Doxorubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Anidulafungin—Rash—Sorafenib—thyroid cancer	0.00159	0.00159	CcSEcCtD
Anidulafungin—Dermatitis—Sorafenib—thyroid cancer	0.00159	0.00159	CcSEcCtD
Anidulafungin—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00158	0.00158	CcSEcCtD
Anidulafungin—Headache—Sorafenib—thyroid cancer	0.00158	0.00158	CcSEcCtD
Anidulafungin—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Anidulafungin—Neutropenia—Epirubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Anidulafungin—Nausea—Sorafenib—thyroid cancer	0.0015	0.0015	CcSEcCtD
Anidulafungin—Hyperglycaemia—Epirubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Anidulafungin—Pneumonia—Epirubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Anidulafungin—Infestation—Epirubicin—thyroid cancer	0.00146	0.00146	CcSEcCtD
Anidulafungin—Infestation NOS—Epirubicin—thyroid cancer	0.00146	0.00146	CcSEcCtD
Anidulafungin—Urinary tract infection—Epirubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Anidulafungin—Neutropenia—Doxorubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Anidulafungin—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Anidulafungin—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Anidulafungin—Pneumonia—Doxorubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Anidulafungin—Infestation NOS—Doxorubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Anidulafungin—Infestation—Doxorubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Anidulafungin—Urinary tract infection—Doxorubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Anidulafungin—Urinary tract disorder—Epirubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Anidulafungin—Oedema peripheral—Epirubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Anidulafungin—Connective tissue disorder—Epirubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Anidulafungin—Urethral disorder—Epirubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Anidulafungin—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Anidulafungin—Visual impairment—Epirubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Anidulafungin—Eye disorder—Epirubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Anidulafungin—Cardiac disorder—Epirubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Anidulafungin—Flushing—Epirubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Anidulafungin—Urinary tract disorder—Doxorubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Anidulafungin—Oedema peripheral—Doxorubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Anidulafungin—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Anidulafungin—Angiopathy—Epirubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Anidulafungin—Urethral disorder—Doxorubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Anidulafungin—Immune system disorder—Epirubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Anidulafungin—Mediastinal disorder—Epirubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Anidulafungin—Chills—Epirubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Anidulafungin—Visual impairment—Doxorubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Anidulafungin—Mental disorder—Epirubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Anidulafungin—Erythema—Epirubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Anidulafungin—Malnutrition—Epirubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Anidulafungin—Eye disorder—Doxorubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Anidulafungin—Flushing—Doxorubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Anidulafungin—Cardiac disorder—Doxorubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Anidulafungin—Back pain—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Anidulafungin—Angiopathy—Doxorubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Anidulafungin—Immune system disorder—Doxorubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Anidulafungin—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Anidulafungin—Chills—Doxorubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Anidulafungin—Vision blurred—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Anidulafungin—Mental disorder—Doxorubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Anidulafungin—Erythema—Doxorubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Anidulafungin—Malnutrition—Doxorubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Anidulafungin—Anaemia—Epirubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Anidulafungin—Leukopenia—Epirubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Anidulafungin—Back pain—Doxorubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Anidulafungin—Cough—Epirubicin—thyroid cancer	0.000997	0.000997	CcSEcCtD
Anidulafungin—Vision blurred—Doxorubicin—thyroid cancer	0.000996	0.000996	CcSEcCtD
Anidulafungin—Convulsion—Epirubicin—thyroid cancer	0.00099	0.00099	CcSEcCtD
Anidulafungin—Hypertension—Epirubicin—thyroid cancer	0.000986	0.000986	CcSEcCtD
Anidulafungin—Anaemia—Doxorubicin—thyroid cancer	0.000977	0.000977	CcSEcCtD
Anidulafungin—Chest pain—Epirubicin—thyroid cancer	0.000973	0.000973	CcSEcCtD
Anidulafungin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000966	0.000966	CcSEcCtD
Anidulafungin—Leukopenia—Doxorubicin—thyroid cancer	0.000946	0.000946	CcSEcCtD
Anidulafungin—Confusional state—Epirubicin—thyroid cancer	0.00094	0.00094	CcSEcCtD
Anidulafungin—Anaphylactic shock—Epirubicin—thyroid cancer	0.000932	0.000932	CcSEcCtD
Anidulafungin—Infection—Epirubicin—thyroid cancer	0.000926	0.000926	CcSEcCtD
Anidulafungin—Cough—Doxorubicin—thyroid cancer	0.000922	0.000922	CcSEcCtD
Anidulafungin—Convulsion—Doxorubicin—thyroid cancer	0.000916	0.000916	CcSEcCtD
Anidulafungin—Nervous system disorder—Epirubicin—thyroid cancer	0.000914	0.000914	CcSEcCtD
Anidulafungin—Thrombocytopenia—Epirubicin—thyroid cancer	0.000913	0.000913	CcSEcCtD
Anidulafungin—Hypertension—Doxorubicin—thyroid cancer	0.000913	0.000913	CcSEcCtD
Anidulafungin—Skin disorder—Epirubicin—thyroid cancer	0.000906	0.000906	CcSEcCtD
Anidulafungin—Hyperhidrosis—Epirubicin—thyroid cancer	0.000901	0.000901	CcSEcCtD
Anidulafungin—Chest pain—Doxorubicin—thyroid cancer	0.0009	0.0009	CcSEcCtD
Anidulafungin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000894	0.000894	CcSEcCtD
Anidulafungin—Hypotension—Epirubicin—thyroid cancer	0.000871	0.000871	CcSEcCtD
Anidulafungin—Confusional state—Doxorubicin—thyroid cancer	0.00087	0.00087	CcSEcCtD
Anidulafungin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000863	0.000863	CcSEcCtD
Anidulafungin—Infection—Doxorubicin—thyroid cancer	0.000857	0.000857	CcSEcCtD
Anidulafungin—Nervous system disorder—Doxorubicin—thyroid cancer	0.000846	0.000846	CcSEcCtD
Anidulafungin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000845	0.000845	CcSEcCtD
Anidulafungin—Insomnia—Epirubicin—thyroid cancer	0.000843	0.000843	CcSEcCtD
Anidulafungin—Skin disorder—Doxorubicin—thyroid cancer	0.000838	0.000838	CcSEcCtD
Anidulafungin—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000834	0.000834	CcSEcCtD
Anidulafungin—Dyspnoea—Epirubicin—thyroid cancer	0.000831	0.000831	CcSEcCtD
Anidulafungin—Dyspepsia—Epirubicin—thyroid cancer	0.000821	0.000821	CcSEcCtD
Anidulafungin—Hypotension—Doxorubicin—thyroid cancer	0.000806	0.000806	CcSEcCtD
Anidulafungin—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000805	0.000805	CcSEcCtD
Anidulafungin—Constipation—Epirubicin—thyroid cancer	0.000797	0.000797	CcSEcCtD
Anidulafungin—Insomnia—Doxorubicin—thyroid cancer	0.00078	0.00078	CcSEcCtD
Anidulafungin—Dyspnoea—Doxorubicin—thyroid cancer	0.000769	0.000769	CcSEcCtD
Anidulafungin—Feeling abnormal—Epirubicin—thyroid cancer	0.000768	0.000768	CcSEcCtD
Anidulafungin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000762	0.000762	CcSEcCtD
Anidulafungin—Dyspepsia—Doxorubicin—thyroid cancer	0.000759	0.000759	CcSEcCtD
Anidulafungin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000745	0.000745	CcSEcCtD
Anidulafungin—Urticaria—Epirubicin—thyroid cancer	0.000741	0.000741	CcSEcCtD
Anidulafungin—Constipation—Doxorubicin—thyroid cancer	0.000738	0.000738	CcSEcCtD
Anidulafungin—Abdominal pain—Epirubicin—thyroid cancer	0.000737	0.000737	CcSEcCtD
Anidulafungin—Body temperature increased—Epirubicin—thyroid cancer	0.000737	0.000737	CcSEcCtD
Anidulafungin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000711	0.000711	CcSEcCtD
Anidulafungin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000705	0.000705	CcSEcCtD
Anidulafungin—Hypersensitivity—Epirubicin—thyroid cancer	0.000687	0.000687	CcSEcCtD
Anidulafungin—Urticaria—Doxorubicin—thyroid cancer	0.000685	0.000685	CcSEcCtD
Anidulafungin—Abdominal pain—Doxorubicin—thyroid cancer	0.000682	0.000682	CcSEcCtD
Anidulafungin—Body temperature increased—Doxorubicin—thyroid cancer	0.000682	0.000682	CcSEcCtD
Anidulafungin—Pruritus—Epirubicin—thyroid cancer	0.00066	0.00066	CcSEcCtD
Anidulafungin—Diarrhoea—Epirubicin—thyroid cancer	0.000638	0.000638	CcSEcCtD
Anidulafungin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000636	0.000636	CcSEcCtD
Anidulafungin—Dizziness—Epirubicin—thyroid cancer	0.000617	0.000617	CcSEcCtD
Anidulafungin—Pruritus—Doxorubicin—thyroid cancer	0.00061	0.00061	CcSEcCtD
Anidulafungin—Vomiting—Epirubicin—thyroid cancer	0.000593	0.000593	CcSEcCtD
Anidulafungin—Diarrhoea—Doxorubicin—thyroid cancer	0.00059	0.00059	CcSEcCtD
Anidulafungin—Rash—Epirubicin—thyroid cancer	0.000588	0.000588	CcSEcCtD
Anidulafungin—Dermatitis—Epirubicin—thyroid cancer	0.000587	0.000587	CcSEcCtD
Anidulafungin—Headache—Epirubicin—thyroid cancer	0.000584	0.000584	CcSEcCtD
Anidulafungin—Dizziness—Doxorubicin—thyroid cancer	0.000571	0.000571	CcSEcCtD
Anidulafungin—Nausea—Epirubicin—thyroid cancer	0.000554	0.000554	CcSEcCtD
Anidulafungin—Vomiting—Doxorubicin—thyroid cancer	0.000549	0.000549	CcSEcCtD
Anidulafungin—Rash—Doxorubicin—thyroid cancer	0.000544	0.000544	CcSEcCtD
Anidulafungin—Dermatitis—Doxorubicin—thyroid cancer	0.000543	0.000543	CcSEcCtD
Anidulafungin—Headache—Doxorubicin—thyroid cancer	0.00054	0.00054	CcSEcCtD
Anidulafungin—Nausea—Doxorubicin—thyroid cancer	0.000512	0.000512	CcSEcCtD
